These emerging medications , Semaglutide , represent a groundbreaking advancement in treating metabolic dysfunction and conceivably other disorders. They are classified as GLP-1 receptor activators , signifying they function to replicate the natural GLP-1 substance , boosting glucose release and reducing appetite . Although Tirzepatide each works l